Fujifilm Strengthens Life Sciences Leadership Across Biomanufacturing and iPSC Businesses FUJIFILM Holdings America Corporation has announced expanded leadership responsibilities for three senior executives across its Life Sciences Group, reinforcing the…
QT Imaging Secures Saudi FDA Approval for Breast Acoustic CT Scanner, Advancing Expansion Across Gulf Healthcare Market QT Imaging Holdings, Inc., a medical device company focused on transforming breast health…
Natera Appoints Oncology Leaders Thomas Lynch and Eric Rubin to Board of Directors to Strengthen Precision Medicine Strategy Natera, Inc., a global leader in cell-free DNA testing and precision medicine…
New Evidence Supports Ketogenic Therapy as a Potential Treatment for Anorexia Nervosa A pilot clinical study published in Communications Medicine has reported promising early evidence that a ketogenic nutritional intervention…
DocGo Expands PTI Health Mobile Phlebotomy Services Into Southern Florida Through Expanded Laboratory Partnership DocGo Inc., a leading provider of technology-enabled mobile health services and medical transportation solutions, has announced…
Terremoto Biosciences Receives FDA Fast Track Designation for TER-2013 in Advanced HR+/HER2- Breast Cancer Terremoto Biosciences, a biotechnology company focused on developing highly targeted small-molecule therapies for cancer, has announced…
Niagen Bioscience Renames Research Program to Strengthen Global Commitment to NAD+ Science and Healthy Aging Research Niagen Bioscience, Inc. (NASDAQ: NAGE), a company focused on advancing the science of healthy…
Gilead Reports Positive Phase 3 Results for Livdelzi in Primary Biliary Cholangitis, Demonstrating Significant Improvement in Liver Disease Marker Gilead Sciences has announced positive topline results from the Phase 3…
Moonlight Therapeutics Launches First-in-Human Phase I Trial of MOON101 for Peanut Allergy Moonlight Therapeutics, Inc., a clinical-stage biotechnology company focused on developing innovative treatments for food allergies, has announced the…
Alliance Clinical Network and Atlas Clinical Research Complete Merger to Create Expanded National Clinical Research Platform Alliance Clinical Network and Atlas Clinical Research have announced the successful completion of a…
Camizestrant Combination Reduced Risk of First and Second Disease Progression in ESR1-Mutant Advanced HR-Positive Breast Cancer in SERENA-6 AstraZeneca has announced updated positive findings from its pivotal Phase III SERENA-6…
Iza-Bren Significantly Improves Overall and Progression-Free Survival in Triple-Negative Breast Cancer and Esophageal Cancer SystImmune, Inc., a clinical-stage biotechnology company focused on developing innovative cancer therapies, and Bristol Myers Squibb…